Read the 120-page report with TOC on "Human Microbiome Therapeutics Market Analysis Report by Application (Gastrointestinal disorders, Infectious Diseases, and Others) and Geographic (North America, Europe, Asia, and ROW), and the Segment Forecasts". Fetch a Sample Report!
Key Market Driver
The rising incidence of chronic diseases is one of the major factors boosting the market for human microbiome treatments. Obesity is mostly caused by the gut microbiome. As a result, efforts to control and design the human microbiome will intensify in the years to come. As a result, the global market for human microbiome treatments is expected to rise over the course of the forecast period due to the rising frequency of chronic disorders that can alter the normal gut flora. Investment expansion is a major element propelling the market for human microbiome therapies.
For more information on the market driver and trends – Click here for a sample now!
Human Microbiome Therapeutics Market Geography Outlook
North America will account for 48% of market growth. In North America, the US is the primary market for human microbiome therapies. Compared to other parts of Europe, this region's market will increase more quickly.
The development of the human microbiome therapeutics market in North America will be aided by elements such sizeable investments in R&D for the creation of novel therapeutic procedures and increasing prevalence of gastrointestinal, metabolic, and immunological illnesses over the forecast period.
Plan and Strengthen your business and marketing strategies, Request Sample Report.
Human Microbiome Therapeutics Market Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The human microbiome therapeutics market report covers the following areas:
This study identifies growing investments from venture capitalists as one of the prime reasons driving the human microbiome therapeutics market growth during the next few years.
Related Reports:
Obsessive-Compulsive Disorder Drugs Market- The obsessive-compulsive disorder drugs market share is expected to increase by USD 266.78 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.55%. Download sample report now!
Over the Counter OTC Drugs and Dietary Supplements Market- The over-the-counter OTC drugs and dietary supplements market share is expected to increase to USD 57.96 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.44%. Download sample report now!
Human Microbiome Therapeutics Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 47.79% |
Market growth 2021-2025 |
$ 516.08 million |
Market structure |
Fragmented |
YoY growth (%) |
52.98 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 48% |
Key consumer countries |
US, Switzerland, Germany, UK, and Japan |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
4D pharma Plc, ENTEROME SA, Ferring B.V., Johnson and Johnson Inc., Kaleido Biosciences Inc., OptiBiotix Health Plc, PureTech Health Plc, Second Genome Therapeutics, Seres Therapeutics Inc., and Takeda Pharmaceutical Co. Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents
1 Executive Summary
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 01: Parent market
- Exhibit 02: Market characteristics
- 2.2 Value chain analysis
- Exhibit 03: Value Chain Analysis: Pharmaceuticals
3 Market Sizing
- 3.1 Market definition
- Exhibit 04: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 05: Market segments
- 3.4 Market outlook: Forecast for 2020 - 2025
- Exhibit 06: Global - Market size and forecast 2020 - 2025 ($ million)
- Exhibit 07: Global market: Year-over-year growth 2020 - 2025 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 08: Five forces analysis 2020 & 2025
- 4.2 Bargaining power of buyers
- Exhibit 09: Bargaining power of buyers
- 4.3 Bargaining power of suppliers
- Exhibit 10: Bargaining power of suppliers
- 4.4 Threat of new entrants
- Exhibit 11: Threat of new entrants
- 4.5 Threat of substitutes
- Exhibit 12: Threat of substitutes
- 4.6 Threat of rivalry
- Exhibit 13: Threat of rivalry
- 4.7 Market condition
- Exhibit 14: Market condition - Five forces 2020
5 Market Segmentation by Application
- 5.1 Market segments
- Exhibit 15: Application - Market share 2020-2025 (%)
- 5.2 Comparison by Application
- Exhibit 16: Comparison by Application
- 5.3 Gastrointestinal disorders - Market size and forecast 2020-2025
- Exhibit 17: Gastrointestinal disorders - Market size and forecast 2020-2025 ($ million)
- Exhibit 18: Gastrointestinal disorders - Year-over-year growth 2020-2025 (%)
- 5.4 Infectious diseases - Market size and forecast 2020-2025
- Exhibit 19: Infectious diseases - Market size and forecast 2020-2025 ($ million)
- Exhibit 20: Infectious diseases - Year-over-year growth 2020-2025 (%)
- 5.5 Others - Market size and forecast 2020-2025
- Exhibit 21: Others - Market size and forecast 2020-2025 ($ million)
- Exhibit 22: Others - Year-over-year growth 2020-2025 (%)
- 5.6 Market opportunity by Application
- Exhibit 23: Market opportunity by Application
6 Customer landscape
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 25: Market share by geography 2020-2025 (%)
- 7.2 Geographic comparison
- Exhibit 26: Geographic comparison
- 7.3 North America - Market size and forecast 2020-2025
- Exhibit 27: North America - Market size and forecast 2020-2025 ($ million)
- Exhibit 28: North America - Year-over-year growth 2020-2025 (%)
- 7.4 Europe - Market size and forecast 2020-2025
- Exhibit 29: Europe - Market size and forecast 2020-2025 ($ million)
- Exhibit 30: Europe - Year-over-year growth 2020-2025 (%)
- 7.5 Asia - Market size and forecast 2020-2025
- Exhibit 31: Asia - Market size and forecast 2020-2025 ($ million)
- Exhibit 32: Asia - Year-over-year growth 2020-2025 (%)
- 7.6 ROW - Market size and forecast 2020-2025
- Exhibit 33: ROW - Market size and forecast 2020-2025 ($ million)
- Exhibit 34: ROW - Year-over-year growth 2020-2025 (%)
- 7.7 Key leading countries
- Exhibit 35: Key leading countries
- 7.8 Market opportunity by geography
- Exhibit 36: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.2 Market challenges
- Exhibit 37: Impact of drivers and challenges
9 Vendor Landscape
- 9.1 Overview
- Exhibit 38: Vendor landscape
- 9.2 Landscape disruption
- Exhibit 39: Landscape disruption
- Exhibit 40: Industry risks
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 41: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 42: Market positioning of vendors
- Exhibit 43: 4D pharma Plc - Overview
- Exhibit 44: 4D pharma Plc - Product and service
- Exhibit 45: 4D pharma Plc - Key offerings
- Exhibit 46: ENTEROME SA - Overview
- Exhibit 47: ENTEROME SA - Product and service
- Exhibit 48: ENTEROME SA - Key offerings
- Exhibit 49: ENTEROME SA - Segment focus
- Exhibit 50: Ferring B.V. - Overview
- Exhibit 51: Ferring B.V. - Product and service
- Exhibit 52: Ferring B.V. - Key offerings
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article